Scientists test Easier-to-Swallow liquid for severe childhood epilepsy
NCT ID NCT07176832
Summary
This study tested how the body absorbs a new liquid form of the drug stiripentol, used for a severe form of childhood epilepsy called Dravet syndrome. Researchers compared it to the standard capsule form in 24 healthy adults to see if they work similarly. The goal is to provide a more convenient, flexible dosing option, especially for young children who have trouble swallowing pills.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
3 Chemin d'Armancourt
Compiègne, 60200, France
-
EUROFINS OPTIMED, 1 rue des Essarts
Gières, 38610, France
Conditions
Explore the condition pages connected to this study.